| CAS Number | 1246819-59-9 |
| Catalog Number | AG009EGA(AGN-PC-0WBMFV) |
| Chemical Name | 3-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide |
| IUPAC Name | 3-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide |
| InChI | InChI=1S/C29H31N7O/c1-21-8-9-25(18-27(21)34-29-31-12-10-26(33-29)24-7-4-11-30-19-24)32-28(37)23-6-3-5-22(17-23)20-36-15-13-35(2)14-16-36/h3-12,17-19H,13-16,20H2,1-2H3,(H,32,37)(H,31,33,34) |
| InChI Key | HIPOQAXTOUMJRW-UHFFFAOYSA-N |
| MDL Number | MFCD30741277 |
| Molecular Formula | C29H31N7O |
| Molecular Weight | 493.6027 |
| SMILES | O=C(NC1=CC=C(C(=C1)NC=2N=CC=C(N2)C3=CN=CC=C3)C)C4=CC=CC(=C4)CN5CCN(C)CC5 |
| Synonyms | 1246819-59-9,
Imatinib Meta-methyl-piperazine,
SCHEMBL6239405,
DTXSID20741185,
ZINC65743052,
ACN-026574,
3-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-pyridinyl)-2-pyrimidinylamino]phenyl]benzamide,
3-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide,
N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-3-((4-methylpiperazin-1-yl)methyl)benzamide,
Imatinib Meta-methyl-piperazine Impurity,
HIPOQAXTOUMJRW-UHFFFAOYSA-N,
|
| Complexity | 714 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 493.259g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 37 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 493.615g/mol |
| Monoisotopic Mass | 493.259g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 86.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.5 |
GHS Hazard and Precautionary Statements
Certificate of Analysis
Lot Number